0001401708-22-000055.txt : 20220303
0001401708-22-000055.hdr.sgml : 20220303
20220303170531
ACCESSION NUMBER: 0001401708-22-000055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BEECHEM JOSEPH M
CENTRAL INDEX KEY: 0001576195
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35980
FILM NUMBER: 22710090
MAIL ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
STREET 2: SUITE 2000
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NanoString Technologies Inc
CENTRAL INDEX KEY: 0001401708
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 200094687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-378-6266
MAIL ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
wf-form4_164634511510830.xml
FORM 4
X0306
4
2022-03-01
0
0001401708
NanoString Technologies Inc
NSTG
0001576195
BEECHEM JOSEPH M
530 FAIRVIEW AVENUE N
SEATTLE
WA
98109
0
1
0
0
SVP, Research & Development
Common Stock
2022-03-01
5
A
0
E
362
30.209
A
78894
D
The purchase period ended March 1, 2022 and is the Purchase Period comprising the Offering Period (as defined in the ESPP) that began September 1, 2021.
The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the NanoString Technologies, Inc. Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of September 1, 2021 through March 1, 2022. This transaction is also exempt under Rule 16b-3(c).
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on March 1, 2022.
/s/ Shannon Atchison, Attorney-in-fact
2022-03-03